A New Ever-Evolving Paradigm
2015; American Medical Association; Volume: 139; Issue: 4 Linguagem: Inglês
10.5858/arpa.2014-0629-ed
ISSN1543-2165
AutoresPhilip T. Cagle, Randall J. Olsen, Bryce P. Portier, Hidehiro Takei, David W. Bernard,
Tópico(s)Cancer Genomics and Diagnostics
ResumoCancer biomarker testing is now a mainstay of 21st century pathology practice, embracing the pathologist's role in patient selection for specific targeted therapies. Pathologists, oncologists, and others require direction in adapting to this new ever-evolving paradigm.The Department of Pathology and Genomic Medicine at Houston Methodist Hospital in Texas hosted the Cancer Biomarker Conference (CBC) on March 22, 2014, at the Houston Methodist Research Institute in association with the department's Houston Methodist Diagnostic Laboratories. The CBC was inspired by the work of the Cancer Biomarker Reporting Committee (CBRC) of the College of American Pathologists (CAP), which cosponsored the conference. The conference covered a range of issues from how to provide a cancer biomarker service and testing/interpretation/reporting/reimbursement issues for biomarker testing, to tissue management and biomarker testing/interpretation for specific solid cancers. Speakers included members of the CBRC, as well as other renowned experts who serve on related CAP committees, and presidents of the CAP, Texas Society of Pathologists (TSP), and the American Society of Clinical Oncology (ASCO). The articles in this first part of a 2-part special section are derived from lectures at the CBC, as well as contributions from other members of the CBRC and faculty at Houston Methodist Hospital.Other cosponsors of the CBC included the Texas Society of Pathologists, Association for Molecular Pathology, American Society for Investigative Pathology, Chinese American Pathologists Association, Florida Society of Pathologists, Oklahoma State Association of Pathologists, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center Department of Translational Molecular Pathology, The University of Texas Health Science Center San Antonio, The University of Texas Medical Branch Galveston, The University of Texas Southwestern Medical Center Dallas, University of Arkansas for the Medical Sciences, The University of Oklahoma Health Sciences Center, and Baylor Scott & White Healthcare-Central. We would specifically like to recognize the following individuals:Primary Sponsors:Department of Pathology and Genomic Medicine, Houston Methodist Hospital, James Musser, MD, PhD, ChairHouston Methodist Research InstituteCAP Cancer Biomarker Reporting Committee:Patrick Fitzgibbons, MD, ChairAlexander Lazar, MD, PhDEric Duncavage, MDApril Fritz, RHITAngela Bartley, MDStanley Hamilton, MDMarian Birkeland, PhD (Liaison—National Comprehensive Cancer Network, NCCN)M. Elizabeth H. Hammond, MDPhilip Cagle, MDTodd Kelley, MDDeborah Dillon, MD (Liaison—Association for Molecular Pathology, AMP)Peter Yu, MD (Liaison—American Society of Clinical Oncology, ASCO)Peggy Adamo, RHIT (Liaison—National Cancer Institute–Surveillance, Epidemiology, and End Results Program, NCI-SEER)Michael Cohen, MDSandra Jones (Liaison—Centers for Disease Control and Prevention–National Program of Cancer Registries, CDC-NPCR)Mary Jane King, CTR (Liaison—North American Association of Central Cancer Registries, NAACCR)Jerri Linn Phillips, MA (Liaison—American College of Surgeons–National Cancer Data Base, AcoS-NCDB)Karen Pollitt (Liaison—American Joint Committee on Cancer, AJCC)Lynette Scholl, MDMollie Cullere, MS (Liaison—HL7 Clinical Genomics Work Group, HL7-CGWG)James Dvorak, MT (American Society for Clinical Pathology, ASCP)Jaleh Mirza, MDSpecial Speakers:Gene Herbek, MD (CAP President)Ed Uthman, MD (TSP President)Peter Yu, MD (ASCO President)Guest Panelists:Timothy Allen, MD, JDJennifer Hunt, MDRaouf Nakhleh, MDKarim Sirgi, MDElisabeth Wagar, MDVIP Attendees:Susan Baer, MDGarth Beinart, MDEric Bernicker, MDDavid Booker, MDBrian Butler, MDJenny Chang, MDJ. Richard Cheney, JDGeorge English, MDRichard Friedberg, MDPatrick Godbey MDRichard Gomez, MDRichard Hausner, MDJames Hernandez, MDKirk Heyne, MDWilliam Hickey, MD, PhDSwami Iyer, MDBharati Jhaveri, MDJoseph Khoury, MDGeorge Kwass, MDRodolfo Laucirica, MDDaniel Lehane, MDGarrett Lynch, MDMary Majumder, JD, PhDBob McGonnagleCharles Millikan, DMinThomas Molina, MD, PhDDavid Novis, MDJuan Olano, MDKevin O'ReillyTejal Patel, MDAlexandria T. Phan, MDBryce Portier, MD, PhDH. Alejander Preti, MDAngel Rodriguez, MDMichael Prystowsky, MD, PhDStanley Robboy, MDJames Robb, MDJoseph Saad, MDStephen Sarewitz, MDMonisha Singh, MDMark Sobel, MD, PhDV. O. Speights Jr, DOMichael Talbert, MDHidehiro Takei, MDBin Teh, MDPaul Valenstein, MDEmily Volk, MDThomas Wheeler, MDBruce Williams, MDIgnacio Wistuba, MDBekra Yorke, MD
Referência(s)